This information was published on 2025-05-22T14:51:11 for IP Right Registration Published.
| Field | Value |
| (210) | 2440413 (IR 1783466) |
| (220) |
26 Jan 2024
|
| (300) |
US, 08 Aug 2023, 98122765
|
| (511) (510) |
Class 5
Pharmaceuticals, namely, bio-pharmaceuticals for the treatment of cancer; stem cells for medical use for the treatment of cancer, cardiovascular diseases, and heritable genetic diseases; medicinal preparations for use in oncology; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely, cancer and cardiovascular diseases and heritable genetic diseases; cellular pharmaceutical preparations for use in oncology and cardio-vascular diseases; living tissue in the nature of chimeric antigen receptor (CAR-T) cells for medical use for the treatment of cancer, cardiovascular diseases, and heritable genetic diseases; pharmaceutical preparations for use in oncology; all of the foregoing to exclude infectious diseases. Class 42 Medical and scientific research and development in the fields of cancer treatment and oncolytic virotherapy; research and development of bio-pharmaceuticals for the treatment of cancer, cardiovascular diseases, and heritable genetic diseases; medical and scientific research in the fields of genetics and oncology; research and development of technology in the fields of stem cells and stem cell therapy for the treatment of cancer, cardiovascular diseases, and heritable genetic diseases; development of genetic therapies and chimeric antigen receptor cell (CAR-T) cell therapies for the treatment of cancer, cardiovascular diseases, and heritable genetic diseases; scientific research and development of cell therapies, namely, chimeric antigen receptor T-cells (CAR-T) to cure solid tumor cancers and other cancers; medical and scientific research services in the fields of genetics, cell therapy, oncology, immuno-oncology; all of the foregoing to exclude infectious diseases. |
| (540) | VYRIAD |
| (550) | Word |
| (730) |
Vyriad, Inc.
|
| (750) |
MBIP
|
Find out more about publications on the About page.